These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8290672)

  • 1. Psychotherapeutic Medications Development Program (PMDP).
    Haigler HJ; Cott JM; Rudorfer MV; Schoenfeld RE; Potter WZ; Vitiello B; Everist HD
    Psychopharmacol Bull; 1993; 29(2):241-7. PubMed ID: 8290672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The National Institute of Mental Health-Psychotherapeutic Medications Development Program (PMDP): status 1993.
    Haigler HJ
    Psychopharmacol Bull; 1994; 30(1):19-22. PubMed ID: 7972624
    [No Abstract]   [Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Institute of Mental Health: Psychotherapeutic Medications Development Program.
    Haigler HJ; Koslow SH
    J Clin Psychopharmacol; 1992 Aug; 12(4):231-3. PubMed ID: 1527224
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug initiatives to improve cognitive function.
    Marder SR
    J Clin Psychiatry; 2006; 67 Suppl 9():31-5; discussion 36-42. PubMed ID: 16965187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dialogue. Prescription for problems? Capitating mental health drugs--the great debate.
    Docherty JP; Browne RA; Farmer M
    Behav Healthc Tomorrow; 1998 Oct; 7(5):32-8. PubMed ID: 10185199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving mental health treatments through comparative effectiveness research.
    Wang PS; Ulbricht CM; Schoenbaum M
    Health Aff (Millwood); 2009; 28(3):783-91. PubMed ID: 19414887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A brief history of the new clinical drug evaluation unit meeting. How it began.
    Prien RF
    Psychopharmacol Bull; 1995; 31(1):3-5. PubMed ID: 7675986
    [No Abstract]   [Full Text] [Related]  

  • 10. Medicaid policy changes in mental health care and their effect on mental health outcomes.
    Cuellar AE; Markowitz S
    Health Econ Policy Law; 2007 Jan; 2(Pt 1):23-49. PubMed ID: 18634670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicine. What are the right targets for psychopharmacology?
    Hyman SE; Fenton WS
    Science; 2003 Jan; 299(5605):350-1. PubMed ID: 12532001
    [No Abstract]   [Full Text] [Related]  

  • 12. Prescribing practices of psychiatrists and primary care physicians caring for children with mental illness.
    Harpaz-Rotem I; Rosenheck RA
    Child Care Health Dev; 2006 Mar; 32(2):225-37. PubMed ID: 16441857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro re nata medication for psychiatric inpatients: time to act.
    Hilton MF; Whiteford HA
    Aust N Z J Psychiatry; 2008 Jul; 42(7):555-64. PubMed ID: 18612858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study.
    Green MF; Nuechterlein KH; Kern RS; Baade LE; Fenton WS; Gold JM; Keefe RS; Mesholam-Gately R; Seidman LJ; Stover E; Marder SR
    Am J Psychiatry; 2008 Feb; 165(2):221-8. PubMed ID: 18172017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for mental illness: the merger of eugenics and the drug industry.
    Sharav VH
    Ethical Hum Psychol Psychiatry; 2005; 7(2):111-24. PubMed ID: 16270459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blending addiction research and practice: strategies for technology transfer.
    Condon TP; Miner LL; Balmer CW; Pintello D
    J Subst Abuse Treat; 2008 Sep; 35(2):156-60. PubMed ID: 18337054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bitter and gilded pills: psychiatry in the light (or shadow) of the pharmaceutical industry].
    Vandereycken W
    Tijdschr Psychiatr; 2006; 48(2):119-29. PubMed ID: 16958195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A collaborative approach to targeted treatment development for schizophrenia: a qualitative evaluation of the NIMH-MATRICS project.
    Bromley E
    Schizophr Bull; 2005 Oct; 31(4):954-61. PubMed ID: 16166607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multicenter psychopharmacologic research and the data bank].
    Cassano GB; Conti L; Massimetti G
    Acta Psychiatr Belg; 1983; 83(3):267-81. PubMed ID: 6356790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.